Published in Case Rep Gastroenterol on July 09, 2008
Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol (2012) 0.93
Embryogenesis of the murine endocrine pancreas; early expression of pancreatic polypeptide gene. Development (1991) 2.28
Isolation and characterization of chicken insulin. Endocrinology (1968) 1.31
Pancreatic-polypeptide-rich regions in human pancreas. Lancet (1978) 1.11
Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology (2005) 1.10
An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg (2006) 1.06
Interventional endoscopic ultrasound in pancreatic diseases. Pancreatology (2006) 1.03
Overview of chronic diarrhea caused by functional neuroendocrine neoplasms. Semin Gastrointest Dis (1999) 0.95
Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome. Am J Pathol (1976) 0.95
Hereditary pancreatic endocrine tumours. Pancreatology (2004) 0.94
Pancreatic polypeptide cell hyperplasia with and without watery diarrhea syndrome. J Surg Oncol (1980) 0.91
Pancreatic apudomas. World J Surg (1979) 0.89
Pancreatic polypeptide-secreting islet-cell tumors. A study of three cases. Am J Pathol (1983) 0.86
Report of a pancreatic polypeptide-producing islet-cell tumour of the pancreas causing the watery diarrhoea, hypokalaemia, achlorhydria syndrome in a 55 year old Zimbabwean African male. Cent Afr J Med (1980) 0.82
Pancreatic polypeptide-producing tumors. Silent lesions of the pancreas? Arch Surg (1984) 0.80
Symptomatic pancreatic polypeptide-secreting tumor of the distal pancreas (PPoma). Int J Gastrointest Cancer (2002) 0.79
Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res (2007) 5.12
Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A (2008) 3.43
Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg (2007) 2.21
An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Mol Cancer Ther (2008) 2.21
Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression. Sci Transl Med (2012) 1.67
Laryngoscopy in thyroid surgery--essential standard or unnecessary routine? Surgery (2007) 1.60
Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. Gut (2012) 1.55
DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. Nat Struct Mol Biol (2010) 1.49
Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer. Cancer Biol Ther (2011) 1.45
Reduced complication rate after modified binding purse-string-mattress sutures pancreatogastrostomy versus duct-to-mucosa pancreaticojejunostomy. Surgeon (2013) 1.41
The role of surgery in the management of recurrent adrenocortical carcinoma. J Clin Endocrinol Metab (2012) 1.29
Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2. Blood (2003) 1.22
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. Cancer Biol Ther (2011) 1.18
Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol (2009) 1.13
Transabdominal preperitoneal versus totally extraperitoneal repair of inguinal hernia: a meta-analysis of randomized studies. Am J Surg (2013) 1.11
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab (2015) 1.07
Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg (2012) 1.06
German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam Cancer (2011) 1.06
Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene. Am J Gastroenterol (2007) 1.03
Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. World J Surg (2004) 0.99
Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg (2005) 0.98
Unique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasia. Eur J Endocrinol (2009) 0.98
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study. J Clin Endocrinol Metab (2014) 0.97
Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. Endocr Relat Cancer (2007) 0.97
Hedgehog inhibition with the orally bioavailable Smo antagonist LDE225 represses tumor growth and prolongs survival in a transgenic mouse model of islet cell neoplasms. Ann Surg (2011) 0.93
Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value. World J Surg (2009) 0.92
Palladin mutation causes familial pancreatic cancer: absence in European families. PLoS Med (2007) 0.91
Variation in precursor lesions of pancreatic cancer among high-risk groups. Clin Cancer Res (2012) 0.89
Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. J Clin Endocrinol Metab (2003) 0.89
Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain. J Clin Endocrinol Metab (2014) 0.89
Expression of the transcription factor snail and its target gene twist are associated with malignancy in pheochromocytomas. Ann Surg Oncol (2009) 0.88
Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families. Fam Cancer (2010) 0.88
Microarray analysis reveals differential expression of benign and malignant pheochromocytoma. Endocr Relat Cancer (2010) 0.88
LCN2 and TIMP1 as Potential Serum Markers for the Early Detection of Familial Pancreatic Cancer. Transl Oncol (2013) 0.88
Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1. Langenbecks Arch Surg (2011) 0.88
Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target. Neuroendocrinology (2007) 0.87
Multiple primary malignancies in patients with sporadic pancreatic endocrine tumors. J Surg Oncol (2008) 0.86
RNASEL germline variants are associated with pancreatic cancer. Int J Cancer (2005) 0.86
PanIN-specific regulation of Wnt signaling by HIF2α during early pancreatic tumorigenesis. Cancer Res (2013) 0.86
Expression of hedgehog signalling pathway in anaplastic thyroid cancer. Endocrine (2013) 0.84
Low frequency of CHEK2 mutations in familial pancreatic cancer. Fam Cancer (2006) 0.84
Clinical impact of TP53 alterations in adrenocortical carcinomas. Langenbecks Arch Surg (2011) 0.84
Neuroendocrine pancreatic tumors are risk factors for pancreatic fistula after pancreatic surgery. Dig Surg (2011) 0.83
Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg (2011) 0.83
Multimodal treatment of sporadic and inherited neuroendocrine tumors of the thymus. Surgery (2008) 0.83
Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors. Langenbecks Arch Surg (2014) 0.82
Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. Pancreatology (2013) 0.82
Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1. Ann Surg (2013) 0.81
Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity. Pancreas (2011) 0.81
Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problems. Int J Mol Sci (2012) 0.81
RIO kinase 3 acts as a SUFU-dependent positive regulator of Hedgehog signaling. Cell Signal (2013) 0.81
Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases. Neuroendocrinology (2015) 0.81
Epithelial-mesenchymal transition is a critical step in tumorgenesis of pancreatic neuroendocrine tumors. Cancers (Basel) (2012) 0.80
Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1. Neuroendocrinology (2013) 0.80
Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model of pancreatic cancer. Langenbecks Arch Surg (2013) 0.80
Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas. J Clin Endocrinol Metab (2015) 0.80
Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumors. Ann Surg (2011) 0.79
Outcome in patients with long-term treatment in a surgical intensive care unit. Langenbecks Arch Surg (2012) 0.79
Cryopreservation of parathyroid tissue after parathyroid surgery for renal hyperparathyroidism: does it really make sense? World J Surg (2012) 0.78
Outcome of surgery for ileojejunal neuroendocrine tumors. Surg Today (2012) 0.78
Alterations of the tissue inhibitor of metalloproteinase-3 (TIMP3) gene in pancreatic adenocarcinomas. Pancreas (2005) 0.77
Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomas. Endocrine (2009) 0.77
Corrigendum: Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1. Nat Commun (2015) 0.76
Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas. Endocr Relat Cancer (2009) 0.76
Sorafenib inhibits tumor growth and improves survival in a transgenic mouse model of pancreatic islet cell tumors. ScientificWorldJournal (2012) 0.76
Are diabetic patients at a greater risk to develop a vocal fold palsy during thyroid surgery than nondiabetic patients? Surgery (2007) 0.76
Duodenal somatostatinoma associated with Von Recklinghausen's disease. J Hepatobiliary Pancreat Surg (2004) 0.76
Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1. Neuroendocrinology (2015) 0.76
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell (2016) 0.76
IGF-1 drives chromogranin A secretion via activation of Arf1 in human neuroendocrine tumour cells. J Cell Mol Med (2015) 0.75
Fast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: a case report. J Med Case Rep (2008) 0.75
Molecular Characterization and Pathogenesis of Intraductal Papillary Mucinous Neoplasms of the Pancreas. Eur Surg Res (2015) 0.75
Over-Expression of miRNA miR-7-5p is a Potential Biomarker in Neuroendocrine Neoplasia of the Small Intestine. Neuroendocrinology (2017) 0.75